BNI invites CEO of Tobinco Pharmaceuticals
The Bureau of National Investigations (BNI) has invited the Chief Executive Officer of Tobinco Pharmaceuticals Limited, Samuel Amo Tobin to assist in investigations following the importation and distribution of about a hundred unregistered drugs. A post market surveillance...
Posted On 28 Sep 2013